| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| BOC-(R)-3-氨基-3-(2,3-二氯苯基)-丙酸 | (R)-3-((tert-Butoxycarbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid | 500788-91-0 | C14H17Cl2NO4 |
| BOC-(R)-3-氨基-2-羟甲基丁酸 | (R)-3-((tert-butoxycarbonyl)amino)-2-(hydroxymethyl)propanoic acid | 1190870-93-9 | C9H17NO5 |
| BOC-(R)-3-噻吩基甘氨酸 | (R)-2-(tert-butoxycarbonylamino)-2-(thiophen-3-yl)acetic acid | 33130-97-1 | C11H15NO4S |
| BOC-(R)-2-甲氧基苯基甘氨酸 | (R)-2-((tert-butoxycarbonyl)amino)-2-(2-methoxyphenyl)acetic acid | 1217786-73-6 | C14H19NO5 |
| BOC-(R)-2-(2-噻吩基)-甘氨酸 | R-tert-butoxyformamido-(2-thienyl)acetic acid | 74562-03-1 | C11H15NO4S |
| BOC-(2S,4S)-4-氨基-1-FMOC-吡咯烷-2-羧酸 | 4-N-tert-butyloxycarbonylamino-N-9-fluorenylmethyloxycarbonyl-L-cis-proline | 221352-74-5 | C25H28N2O6 |
| BOC-(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-METHYLBENZYL)PYRROLIDINE-2-CARBOXYLICACID(2S,4R)-1-(叔丁氧基羰基)-4-(4-甲基苄基)吡咯烷-2-羧酸 | Boc-(R)-4-(4-methylbenzyl)-L-proline | 959581-21-6 | C18H25NO4 |
| BOC-(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(3-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLICACID(2S,4R)-1-(叔丁氧基羰基)-4-(3-氟苄基)吡咯烷-2-羧酸MFCD06659389 | (2S,4R)-1-(tert-butoxycarbonyl)-4-(3-fluorobenzyl)pyrrolidine-2-carboxylic acid | 959579-74-9 | C17H22FNO4 |
| BOC-(2S,3R)-3-氨基-2-羟基-4-(4-硝基苯基)丁酸 | (2S,3R)-3-(Boc-amino)-2-hydroxy-4-(4-nitrophenyl)butyric acid | 112898-24-5 | C15H20N2O7 |
| BNPS-粪臭素 | BNPS-Skatole | 27933-36-4 | C15H11BrN2O2S |
| BMS470539二盐酸盐 | (2S)-2-Amino-N-[(2R)-1-(4-butanoyl-4-phenylpiperidin-1-yl)-3-(4-methoxyphenyl)-1-oxopropan-2-yl]-3-(3-methylimidazol-4-yl)propanamide | 457893-92-4 | C32H41N5O4 |
| BMS202(PD-1/PD-L1抑制剂2) | BMS-202 | 1675203-84-5 | C25H29N3O3 |
| BMS-687453抑制剂 | BMS-687453 | 1000998-59-3 | C22H21ClN2O6 |
| BMS 754807; (2S)-1-[4-[(5-环丙基-1H-吡唑-3-基)氨基]吡咯并[2,1-f][1,2,4]三嗪-2-基]-N-(6-氟-3-吡啶基)-2-甲基-2-吡咯烷甲酰胺 | BMS-754807 | 1001350-96-4 | C23H24FN9O |
| BMS 740808; 1-(3-氨基-1,2-苯并[d]异噁唑-5-基)-3-三氟甲基-6-[4-[2-[[(3R)-3-羟基-1-吡咯烷基]甲基]苯基]苯基]-1,4,5,6-四氢-7H-吡唑并[3,4-c]吡啶-7-酮 | BMS-740808 | 280118-23-2 | C31H27F3N6O3 |
| BMS 554417; 4-[2-[4-[[(2S)-2-(3-氯苯基)-2-羟基乙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-7-甲基-1H-苯并咪唑-5-基]-1-哌嗪丙腈 | BMS-554417 | 468741-42-6 | C28H30ClN7O2 |
| BMS 378806; 1-[(2R)-4-苯甲酰基-2-甲基-1-哌嗪基]-2-(4-甲氧基-1H-吡咯并[2,3-b]吡啶-3-基)-1,2-乙二酮 | 4-benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine | 357263-13-9 | C22H22N4O4 |
| BMIK 双(1-甲基-2-咪唑基)甲酮 | bis(N-methylimidazol-2-yl)keton | 62366-40-9 | C9H10N4O |
| BM15766硫酸盐 | 4-[2-[4-[3-(4-Chlorophenyl)-2-propenyl]-1-piperazinyl]ethyl]benzoic acid sulfate | 86621-94-5 | C22H27ClN2O6S |
| BLU-667(拉西替尼) | Pralsetinib | 2097132-94-8 | C27H32FN9O2 |
| BLU-554中间体 | 2-chloro-6-(3,5-dimethoxyphenyl)quinazoline | 1538605-05-8 | C16H13ClN2O2 |
| BLI489水合物 | BLI-489 | 623564-40-9 | C13H10N3O4S*Na |
| BL-1021盐酸盐 | BL-1021 hydrochloride | 1002331-76-1 | C23H28N2O*ClH |
| BIXNHE1抑制剂 | 4-(1-acetylpiperidin-4-yl)-N-carbamimidoyl-3-(trifluoromethyl)benzamide;hydrochloride | 1422252-46-7 | C16H19F3N4O2*ClH |
| BIX01294TrihydrochlorideHydrateBIX01294三盐酸盐水合物 | N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine trihydrochloride | 1392399-03-9 | C28H41Cl3N6O2 |
| BISTHFHNS衍生物3 | 2,5-dioxopyrrolidin-1-yl ((3R,3aR,6aS)-hexahydrofuro[2,3-b]furan-3-yl) carbonate | 799241-86-4 | C11H13NO7 |
| BIS-四聚乙二醇-磺酸 | Bis-PEG4-sulfonic acid | 1807539-08-7 | C10H22O10S2 |
| BIS-MUP,二(4-甲基伞形酮)磷酸酯 | Di(4-methylcumarin-7-yl)phosphat | 51379-07-8 | C20H15O8P |
| BIP抑制剂(HA15) | HA15 | 1609402-14-3 | C23H22N4O3S2 |
| BIOTIN-六聚乙二醇-叠氮 | N-(20-azido-3,6,9,12,15,18-hexaoxaicosyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide | 1085938-09-5 | C24H44N6O8S |
| BIOTIN-三聚乙二醇 | 5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]pentanamide | 289714-02-9 | C16H29N3O5S |
| BIIE 246 | (S)-N<sup>2</sup>-[[1-[2-[4-[(R,S)-5,11-dihydro6(6h)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxo-ethyl]-cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]-argininamid | 246146-55-4 | C49H57N11O6 |
| BIIB-024; 6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶基]氨基]羰基]-2-噻唑基]乙基]-4-嘧啶甲酰胺 | (R)-2-(1-(6-amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide | 1096708-71-2 | C17H12Cl2F3N7O2S |
| BIIB 021; 6-氯-9-[(4-甲氧基-3,5-二甲基-2-吡啶基)甲基]-9H-嘌呤-2-胺 | BIIB021 | 848695-25-0 | C14H15ClN6O |
| BIBF1120中间体 | methyl (E)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate | 1168150-46-6 | C18H15NO4 |
| BI-847325,MEK和极光激酶(AK)的ATP竞争性双重抑制剂 | (Z)-3-(3-(((4-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide | 1207293-36-4 | C29H28N4O2 |
| BI(甲基硒)乙炔 | bi(methylseleno)acetylene | 62943-62-8 | C4H6Se2 |
| BHQ-1酸,BHQ-1ACID | BHQ-1 carboxylic acid | 1190431-95-8 | C26H28N6O5 |
| BHQ-1氨基 | BHQ-1 amine | 1308657-79-5 | C25H29N7O3 |
| BG45,一个HDACI型抑制剂,选择性抑制HDAC3 | BG45 | 926259-99-6 | C11H10N4O |
| BEZ235 对甲苯磺酸盐 | 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile monotosylate salt | 1028385-32-1 | C7H8O3S*C30H23N5O |
| BET溴区抑制剂(CPI-0610) | 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide | 1380087-89-7 | C20H16ClN3O2 |
| BETRIXABAN中间体 | 4-(N,N-dimethylcarbamimidoyl)benzoic acid | 244257-76-9 | C10H12N2O2 |
| BETA淀粉样蛋白片段1-40 | Human beta-amyloid peptide (1-40) | 131438-79-4 | C194H295N53O58S |
| BETA2-澳洲茄边碱 | L-Rhamnopyranosyl-14-D-glucopyranose solasodine | 32449-98-2 | C39H63NO11 |
| BETA-雌二醇 3-硫酸钠盐 | (17β)-3-(sulfooxy)estra-1,3,5(10)-trien-17-ol sodium salt | 4999-79-5 | C18H23O5S*Na |
| BETA-萘乙酸甲酯 | methyl 2-naphthylacetate | 2876-71-3 | C13H12O2 |
| BETA-胡萝卜素 | Perhydro-β-carotin | 17161-33-0 | C40H78 |
| BETA-育亨宾 | (+/-)-β-yohimbine | 549-84-8 | C21H26N2O3 |
| BETA-羟基乙基氟灭酸酯 | 2-(3-Trifluoromethyl-phenylamino)-benzoic acid 2-hydroxy-ethyl ester | 32508-98-8 | C16H14F3NO3 |